Figure 1 (Haegarda 01)
Haegarda Kit
Product Images NDC 63833-829
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Haegarda (NDC 63833-829). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Csl Behring Gmbh, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Haegarda 02)
Figure 3 (Haegarda 03)
Figure 4 (Haegarda 04)
Figure 5 (Haegarda 05)
Figure 6 (Haegarda 06)
Figure 7 (Haegarda 07)
Figure 8 (Haegarda 08)
Figure 9 (Haegarda 09)
Figure 10 (Haegarda 10)
Figure 11 (Haegarda 11)
Figure 12 (Haegarda 12)
Principal Display Panel (Kit Carton)
Principal Display Panel (Kit Carton)
Haegarda 15
Haegarda 16
Haegarda 17
Haegarda 18
Haegarda 19
Haegarda 20
Haegarda 21
HAEGARDA is a human product made from C1 Esterase Inhibitor and is intended for subcutaneous administration only. The manufacturer is CSL Behring located in Germany with a US office in Kings, USA. It should be stored in a refrigerator at a temperature of 2 to 25°C and should not be used after the expiry date. The rest of the document is not readable, possibly due to poor .*
Haegarda 22
HAEGARDA is a subcutaneous medication used for treating human asthma caused by C1 esterase inhibitor. Caution needs to be observed as per food safety warnings and precautions outlined in the section. Storage of the medicine must be done up to 30°C. The medicine should only be administered via subcutaneous injection. The rest of the text is not readable.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
